Orbifloxacin
Cat. No.：YN251165
| 产品名称: | Orbifloxacin |
| CAS No.: | 113617-63-3 |
| Chemical Name: | 1-cyclopropyl-7-[(3R,5S)-3,5-dimethyl-1-piperazinyl]-5,6,8-trifluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid |
| Synonyms: | CP-104354 |
| 分子量: | 395.38 |
| 分子式: | C₁₉H₂₀F₃N₃O₃ |
| SMILES: | O=C(C1=CN(C2CC2)C3=C(C(F)=C(F)C(N4C[C@H](C)N[C@H](C)C4)=C3F)C1=O)O |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | Orbifloxacin是一种合成的氟喹诺酮类广谱抗生素，已被批准用于犬类。 |
| IC50和靶点: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
Haines, G.R., Brown, M.P., Gronwall, R.R., et al.Pharmacokinetics of orbifloxacin and its concentration in body fluids and in endometrial tissues of maresCan. J. Vet. Res.65(3),181-187(2001)
Gebru, E., Lee, J.S., Chang, Z.Q., et al.Integration of pharmacokinetic and pharmacodynamic indices of orbifloxacin in beagle dogs after a single intravenous and intramuscular administrationAntimicrob. Agents Chemother.53(7),3024-3029(2009)
